Top of page

Experience

To find Davis Polk deals and cases of particular interest, select filters based on practice, industry, region, lawyer and keyword.

Filters

Global Blood Therapeutics, Inc. Follow-On Offering
Davis Polk advised the joint book-running managers in connection with the $120 million follow-on offering of common stock of Global Blood Therapeutics, Inc. Global Blood’s common stock is…
Spark Therapeutics Follow-On Offering
Davis Polk advised the representative of the underwriters in connection with the $181 million public offering of 4,025,000 shares of common stock of Spark Therapeutics, Inc. (“Spark”),…
Ardmore Shipping Corporation Offering of Common Stock
Davis Polk advised the representative of the underwriters in connection with the approximately $67 million SEC-registered offering of 7,500,000 shares of common stock of Ardmore Shipping…
Lam Research Corporation $2.4 Billion Notes Offering
Davis Polk advised the joint book-running managers on the SEC-registered offering by Lam Research Corporation of $800 million aggregate principal amount of its 2.800% senior notes due 2021,…
Yara International ASA $500 Million Notes Offering
Davis Polk advised the joint bookrunners in connection with a Rule 144A/Regulation S offering by Yara International ASA of $500 million principal amount of 3.800% notes due 2026…
Back to top